Luo, S.; Wu, L.; Li, M.; Wang, J.; Wang, C.; Yang, J.; Zhang, L.; Ge, J.; Sun, C.; Li, E.;
et al. Validation of the Prognostic Role for Surgical Treatment in Stage II Intrahepatic Cholangiocarcinoma: A SEER Population-Based Study. J. Clin. Med. 2023, 12, 675.
https://doi.org/10.3390/jcm12020675
AMA Style
Luo S, Wu L, Li M, Wang J, Wang C, Yang J, Zhang L, Ge J, Sun C, Li E,
et al. Validation of the Prognostic Role for Surgical Treatment in Stage II Intrahepatic Cholangiocarcinoma: A SEER Population-Based Study. Journal of Clinical Medicine. 2023; 12(2):675.
https://doi.org/10.3390/jcm12020675
Chicago/Turabian Style
Luo, Shuaiwu, Linquan Wu, Min Li, Jiakun Wang, Cong Wang, Jun Yang, Ligan Zhang, Jin Ge, Chi Sun, Enliang Li,
and et al. 2023. "Validation of the Prognostic Role for Surgical Treatment in Stage II Intrahepatic Cholangiocarcinoma: A SEER Population-Based Study" Journal of Clinical Medicine 12, no. 2: 675.
https://doi.org/10.3390/jcm12020675
APA Style
Luo, S., Wu, L., Li, M., Wang, J., Wang, C., Yang, J., Zhang, L., Ge, J., Sun, C., Li, E., Lei, J., Zhou, F., & Liao, W.
(2023). Validation of the Prognostic Role for Surgical Treatment in Stage II Intrahepatic Cholangiocarcinoma: A SEER Population-Based Study. Journal of Clinical Medicine, 12(2), 675.
https://doi.org/10.3390/jcm12020675